Revelation Biosciences Inc (REVB) — Cash Flow Quality Index
Revelation Biosciences Inc (REVB) has a Cash Flow Quality Index of -0.26x as of March 2023. Operating cash flow of $-1.58 Million is below net income of $6.16 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore REVB long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Revelation Biosciences Inc Cash Flow Quality Index (2015–2018)
Historical Cash Flow Quality Index for Revelation Biosciences Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Revelation Biosciences Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Revelation Biosciences Inc (2015–2018)
Year-by-year earnings quality comparison for Revelation Biosciences Inc. For live market cap and the full company financial profile, see Revelation Biosciences Inc (REVB) total market value.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2018 | 1.18x | $32.58 Million | $27.63 Million | ▼ -20.9% |
| 2017 | 1.49x | $24.25 Million | $16.27 Million | ▲ +12.8% |
| 2016 | 1.32x | $11.60 Million | $8.78 Million | ▼ -29.3% |
| 2015 | 1.87x | $11.60 Million | $6.20 Million | — |